AG
ORTX

Advisor Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Advisor Group’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
13
– – ﹤0.01% 5042
2019
Q3 		$2K Buy
+13
New +$1.81K ﹤0.01% 5021

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Advisor Group's ORTX Position: Q4 2019 in Review

Advisor Group held its Orchard Therapeutics plc American Depositary Shares (ORTX) position steady in Q4 2019 at 13 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5042.

Advisor Group first reported a position in ORTX in Q3 2019 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold ORTX as of Q4 2019.

  • Advisor Group held 13 shares of Orchard Therapeutics plc American Depositary Shares worth $2K as of Q4 2019.
  • Advisor Group left its Orchard Therapeutics plc American Depositary Shares share count unchanged in Q4 2019.
  • Orchard Therapeutics plc American Depositary Shares made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5042 holding.
  • Advisor Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2019 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.